Autoantigen-specific B-cell depletion overcomes failed immune tolerance in type 1 diabetes.
Autoantigen-specific B-cell depletion overcomes failed immune tolerance in type 1 diabetes.
复制标题
作者:
Henry RA;Kendall PL;Thomas JW
Eliminating autoantigen-specific B cells is an attractive alternative to global B-cell depletion for autoimmune disease treatment. To identify the potential for targeting a key autoimmune B-cell specificity in type 1 diabetes, insulin-binding B cells were tracked within a polyclonal repertoire using heavy chain B-cell receptor (BCR) transgenic (VH125Tg) mice. Insulin-specific B cells are rare in the periphery of nonautoimmune VH125Tg/C57BL/6 mice and WT/NOD autoimmune mice, whereas they clearly populate 1% of mature B-cell subsets in VH125Tg/NOD mice. Autoantigen upregulates CD86 in anti-insulin B cells, suggesting they are competent to interact with T cells. Endogenous insulin occupies anti-insulin BCR beginning with antigen commitment in bone marrow parenchyma, as identified by a second anti-insulin monoclonal antibody. Administration of this monoclonal antibody selectively eliminates insulin-reactive B cells in vivo and prevents disease in WT/NOD mice. Unexpectedly, developing B cells are less amenable to depletion, despite increased BCR sensitivity. These findings exemplify how a critical type 1 diabetes B-cell specificity escapes immune tolerance checkpoints. Disease liability is corrected by eliminating this B-cell specificity, providing proof of concept for a novel therapeutic approach for autoimmune disease.
登录
查看更多内容
影响因子:
3.2
作者:
Henry, Rachel A.;Kendall, Peggy L.;Thomas, James W.
通讯作者:
Thomas, James W.
影响因子:
15.9
作者:
Menard, Laurence;Saadoun, David;Meffre, Eric
通讯作者:
Meffre, Eric
DOI:
10.4049/jimmunol.0803121
发表时间:
2009-03-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Henry RA;Acevedo-Suárez CA;Thomas JW
通讯作者:
Thomas JW
影响因子:
15.3
作者:
Benschop, RJ;Melamed, D;Cambier, JC
通讯作者:
Cambier, JC
影响因子:
64.8
作者:
BAEKKESKOV, S;NIELSEN, JH;LERNMARK, A
通讯作者:
LERNMARK, A